Taisho's Strong Showing In Japan Offsets Lower Sales In Europe
Japan's Taisho reported higher sales in the six months ended 30 September as the continued recovery of the domestic OTC market offset a weaker performance overseas.
You may also be interested in...
Unilever's decision not to increase its £50bn bid for GSK Consumer Healthcare has been widely welcomed by analysts. But they warn that the aborted move for GSK has damaged investor confidence in Unilever’s management.
UK-based Alliance Pharma saw sales rise double-digits in 2021, with acquisitions bolstering the performance of its established brands. Going into 2022, the company says it is in a strong position to pursue M&A in the consumer health space.
France's medicines regulator ANSM has added 12 OTCs to its "free access" list of products available for self-selection by consumers in pharmacies.